Simple Summary Recently, biomarkers have become a supplemental tool to aid in the
diagnosis and evaluation of prostate cancer. Numerous biomarkers are being developed …

Background The clinical pathway to detect and diagnose prostate cancer has been
revolutionised by the use of multiparametric MRI (mpMRI pre-biopsy). mpMRI however …

Background The detection of prostate cancer requires histological confirmation in biopsy
core. Currently, number of unnecessary prostate biopsies are being performed in the United …

Abstract Context Prostate cancer (PCa) is the second most common type of cancer in men.
Individualized risk stratification is crucial to adjust decision-making. A variety of molecular …

Objective To describe early experience of replacing PSA with Stockholm3 for detection of
prostate cancer in primary care. Design and methods Longitudinal observations, comparing …

Simple Summary PTX3 could be a potential biomarker for PCa. To predict anyPCa and
csPCa biomarker PTX3 was evaluated before PBx. Among the 455 eligible patients, PCa …

Simple Summary In this multicentric study, we tested the accuracy of multiparametric
magnetic resonance imaging (mpMRI) in detecting extracapsular extension (ECE) out of the …

The benefits and drawbacks of the dynamic contrast‐enhanced MRI sequence for prostate
cancer diagnosis are increasingly being recognized, with many centers adopting the …

Abstract Background Prostate Imaging-Reporting and Data System (PI-RADS) category 3 is
a challenging scenario for detection of clinically significant prostate cancer (csPCa) and …

Abstract Background: Prostate cancer (PCa) represents one of the most frequent
malignancies and the fifth leading cause of cancer death in adult men worldwide. PCa …